-
European Commission approves Roche MabThera for treatment of adult patients with moderate to severe normal herpes
Time of Update: 2020-06-10
PV is a rare, serious and potentially life-threatening autoimmune disease characterized by progressive pain blistering in the skin and mucous membranes, accounting for about 80% of herpes cases re
-
Sandex biosimilar Ziextenzo (pegfilgrastim) gets European Commission approval
Time of Update: 2020-06-10
recently, Swiss Pharmaceuticals (http:// 's generic unit Sandoz announced that the European Commission (EC) has approved the biosimilar Zixenzo (Pegfilgrastim), for the full adaptation of the alle
-
New drug Lishimin ® (Lisna peptide injection) New indications have been officially approved by China's State Drug Administration
Time of Update: 2020-06-10
Sanofi China has announced that a new drug for the treatment of type 2 diabetes, (http:// the Lissin ® (Lisnapeptide Injection), has been officially approved by China's national drug (http://
-
European Medicines Agency grants lead drug A4250 for orphan medicine for daredevil atresia
Time of Update: 2020-06-10
bile duct atresia is a rare and life-threatening liver disease, and there is no approved treatment drug (http:// recently, the of the http:// the company of Albireo Pharma, announced that the
-
FDA approves Novartis Egaten for treatment of tablet-sucking disease patients over 6 years of age
Time of Update: 2020-06-10
tablet stoma, also known as liver sucking infection, is a neglected tropical disease There are about 2.4 million patients worldwide, and another 180 million people are at risk today, Novartis (ht
-
Fda grants Therachon company apraglutide treatment for orphan drug for short bowel syndrome
Time of Update: 2020-06-10
short bowel syndrome (SBS) is caused by extensive intestinal removal caused by chronic inflammatory bowel disease (IBD), acute events (such as intestinal infarction), or congenital abnormalities re
-
Puli PharmaceuticalS Injection Volikonazole (200mg) approved by FDA
Time of Update: 2020-06-10
recently, Pharmaceutical (http:// announced in a that company (http:// production of the injection vooliconazole (200mg) through the FDA (http:// approval, eligible to sell in the United St
-
FDA approves Praluent to reduce risk of angina
Time of Update: 2020-06-10
recently, Regeneron Pharmaceuticals and Sanofi announced that The FDA (http:// approved a joint development of the praluent to reduce the risk of heart attack, stroke and heart pain in patients w
-
First three-part tablets approved by Japanese regulators for treatment of hypertension
Time of Update: 2020-06-10
recently, Daiichi Sankyo, a Japanese pharmaceutical company, announced that 1.25mg, 2.5mg and 5mg tablets of the esaxerenone had been approved by Japanese regulators to treat high blood pressure Mi
-
FDA approves listing of interferon gamma (IFN) antibody Gamifant (emapalumab-lzsg)
Time of Update: 2020-06-10
today, Sobi and Novimmune SA (http:// jointly announced that the U.S FDA (http:// approved the joint development of the interferon (IFN)antibody Gamifant (emapalumab-lzg) for the treatment of
-
European Commission approves Mercadon Keytruda for assisted treatment of melanoma and lymph nodes in adult patients
Time of Update: 2020-06-10
recently, the cancer immunotherapy giant Merck and Co announced that the European Commission (EC) has approved the PD-1 tumor immunotherapy Keytruda (Chinese commodity name: Creeda, generic name: pe
-
FDA accelerates approval of Tecentriq joint Abraxane first-line treatment of triple-yin breast cancer
Time of Update: 2020-06-10
recently, Genentech announced FDA (http:// accelerated approval of Tecentriq's combination abraxane (albumin yew alcohol) first-line treatment of PD-L1-positive partially rectocted prestage or me
-
ADHD reaches major endpoint in two key Phase 3 clinical trials
Time of Update: 2020-06-10
ADHD, commonly known as ADHD, is a chronic brain disease that manifests itself as unable to concentrate, hyperactivity and impulsiveness today, Supernus Pharmaceuticals (http:// announced that i
-
FDA approves Pfizer Ibrance joint drug to treat male breast cancer patients
Time of Update: 2020-06-10
recently, Pfizer (http:// announced that the U.S FDA (http:// approved the company's heavy-weight breast cancer treatment Ibrcicsito in conjunction with aromatase inhibitors or fuforvestts to
-
FDA grants Enzyvant's RVT-801 rare pediatric disease eligibility and fast-track eligibility
Time of Update: 2020-06-10
Farber disease is a rare and considered significantly underdiagnosed disease, often misdiagnosed as juvenile isopathic arthritis The disease is caused by mutations in the ASAH1 gene, which cause the
-
FDA grants AK1/2 inhibitor Olumiant (baricitinib) fast-track eligibility to treat systemic lupus erythematosus
Time of Update: 2020-06-10
recently , http:// giant Eli Lilly and partner Incyte http:// announced that the u.S Food and Drug (http:// Administration ( ) of the FDA (http:// had granted JAK1/2 inhibitor, The Baricit
-
Advances in new research on the bioimmune anti-cancer drug YS-ON-001
Time of Update: 2020-06-10
Today, the company, the http:// Pharmaceutical (http:// Limited , announced http:// that the company's immuno-cancer drug (http:// YS-ON-001 has made new research progress, with excellent tum
-
Baiyang Pharmaceutical metformin new drug Nida in the United States approved by the FDA
Time of Update: 2020-06-10
recently, baiyang Pharmaceutical (http:// announced that the company (http:// of high-end generic drugs, the use of osmosis pump-controlled release technology metformin new drug (http:// th
-
Bayer's new gynaecological drug, Visanne, has been approved by Chinese regulators to treat endometriosis
Time of Update: 2020-06-10
, Germany's pharmaceutical (http:// giant Bayer announced that , the http:// new drug in the of gynaecology, , was approved by Chinese regulators for the treatment of endometriosis (EMs) Visanne
-
Sanofi fexinidazole approved by DRC for treatment of sleeping sickness
Time of Update: 2020-06-10
recently, French Pharmaceutical (http:// giant Sanofi announced that fexinidazole has been approved by the Democratic Republic of the Congo (DRC) to treat the tripanos bruceomaiense human African